“Needle-Free Delivery Technology market set to grow to $2.7bn by 2022” says new Visiongain report

21 August 2018
Pharma

Visiongain’ has launched a new pharma report Needle-Free Delivery Technology Market  2018-2028: Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology.

The growth of the needle-free delivery technology is driven by unmet needs such as the high incidence of needlestick injuries and the need for a more efficient method of delivering mass vaccinations in rural areas. The market will also be boosted by biological drugs and the rapid growth in emerging market patient populations with access to novel medical devices.

In this report, needle-free drug delivery technologies encompass two types of injector technologies — jet injector technology and the competing needle-free technologies (novel needle technology, inhaler technology and transdermal patch technology). Novel needle technologies include both pen needles and microneedles.

The lead analyst of the report commented "It is anticipated that the future will see continued growth in biologics-drug delivery partnering deals. Visiongain predicts that manufacturers will look to novel self-administration devices as a key way to compete as the biosimilar market continues to rise over the next few years. Moreover, the diabetes biologic drug market represents a major driver for the needle-free delivery technology market."

Leading companies featured in the report include 3M, Antares Pharma, Becton Dickinson, BioJect Medical Technologies, PharmaJet, Zogenix.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031

Contract manufacturing outsourcing is gaining attraction owing to growing trend of outsourcing among pharmaceutical businesses.

16 November 2021

Read

Visiongain Publishes Biosimilars and Follow-On Biologics Market Report 2021-2031

The potential for digital & analytics applications in the pharmaceutical and biotechnology sector has grown dramatically in recent years as a result of fast technological advances as well as changes in the market environment & stakeholder behaviour as a result of the pandemic.

04 November 2021

Read

Visiongain Publishes Pharmaceutical Spray Drying Market Report 2021-2031

The rising prevalence of oncological disorders, lung infections, rising demand for customised drugs coupled with new orphan diseases discoveries, are few of the major reasons responsible for development of pharmaceutical spray drying market.

25 October 2021

Read

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever